CONFERENCE AGENDA. Empowering Your Clinical Trial Operations Through Digital Innovation. 5 6 December 2018, Grand Copthorne Waterfront, Singapore

Transcription

1 CONFERENCE AGENDA Empowering Your Clinical Trial Operations Through Digital Innovation 5 6 December 2018, Grand Copthorne Waterfront, Singapore Researched & Developed by

2 CONFERENCE DAY ONE: WEDNESDAY, 5 DECEMBER :00 Morning Registration & Coffee 09:00 Chairman s Opening Remarks Dr. Nishant Sangole, Head Of Medical Affairs, ASEAN region, Mitsubishi Tanabe Pharma Singapore INNOVATING CLINICAL TRIAL OPERATION THROUGHTECHNOLOGY: THE BIG PHARMA S PERSPECTIVE 09:10 KEYNOTE Keynote Case Studies: Digitalizing Clinical Trial Execution and Optimising Outcomes by Patient-Centric Approach in Next-generation Clinical Trials Dr. Nishant Sangole, Head Of Medical Affairs, ASEAN region, Mitsubishi Tanabe Pharma Singapore 09:50 AstraZeneca Case Study: Integrating Real World Evidence and Patient-Generated Data to Provide Credible and Unbiased Medical Information Aman Kapil Butta, Medical Affairs, AstraZeneca 10:30 Speed Networking Session & Morning Break DESIGN AND DEVELOPMENT OF INNOVATIVE CLINICAL TRIALS STRATEGIES Achieving Innovative Clinical Trial Operations In APAC Through Strategic Partnership 11:15 Moderator: Dr. Phil Masters Clinical Consultant Medicins Sans Frontiere Switzeland Timothy Low APAC Medical Head Shire Hailey Hu Investor B Capital Group Yow Wei Ter Site Relationship and Operations Lead Merck Serono 12:00 Partnership in Investigator Initiated Trials A perspective from Singapore Dr. Teoh Yee Leong, CEO, Singapore Clinical Research Institute

3 12:40 Networking Lunch STEP BY STEP INNOVATION DURING CLINICAL TRIALS OPERATION Roundtable Discussion- (2 45 Mins) 13:40 R Roundtable Ae B Getting Yourself Ready by having a solid Clinical Innovation Strategy Hailey Hu Investor B Capital Group Rou Roundtable B E Optimizing Clinical Trials Operation Through New Partnership Model 15:10 Networking Break Optimizing Protocol Design By Building a New Partnership Models Between Government, Pharma Companies, KOL, Advisory boards and CRO 15:40 Moderator: Dr. Phil Masters Clinical Consultant Medicins Sans Frontiere Switzeland Dr. Nishant Sangole Head Of Medical Affairs, ASEAN Region Mitsubishi Tanabe Pharma Singapore Yow Wei Ter Site Relationship and Operations Lead Merck Serono Dr. Teoh Yee Leong, CEO, Singapore Clinical Research Institute 16:25 Customizing Your Clinical Trial Operation by Innovating Your Partnership Model Zoe Doran, Head of Clinical Trials Support Group, Mahidol Oxford Tropical Medicine Research Unit 17:05 Closing Remarks from Chairperson & End of Conference Day 1

4 CONFERENCE DAY TWO: THURSDAY, 6 DECEMBER :00 Morning Registration & Coffee 09:00 Chairman s Opening Remarks ACHIEVING PATIENT-CENTRIC MANAGEMENT UTILIZING DIGITAL SOLUTIONS 09:10 Novo Nordisk Case Study: Achieving Efficient Patient Recruitment And Retention by Cost-Effective Site Operation Dr. Shweta Uppal, Head- Clinical, Medical, Regulatory, Quality and Pharmacovigilance, Novo Nordisk 09:50 Transforming Your Clinical Trial Operation By Implementing Artificial Intelligence Emily Tan, Corporate Vice President, Portfolio Leadership, PAREXEL 10:30 Speed Networking Session & Morning Networking Break DIGITAL SOLUTIONS TO EMPOWER CLINICAL TRIALS OPERATION Roundtable Discussion- (2 35 Mins) 11:15 Roundtable C Establishing Solid Framework for mhealth Implementation Roundtable D How To Get Higher ROI For Technology Implementation? 12:25 Networking Lunch LEVERAGING DATA ANALYTICS TO INTEGRATE REAL WORLD DATA COLLECTED FROM A WIDE RANGE OF RESOURCES AND MAKING IT UNDERSTANDABLE 13:25 Leveraging Real World Evidence to Get Greater Insights Dr. Hemant Singh Bhadauria, Associate Director- Oncology, Medical Affairs Asia Oceania, Astellas Pharma

5 Decentralised Clinical Trials Providing an Opportunity to Enable Radical Transformation in Clinical Trial Methodology 14:05 Moderator Emily Tan Corporate Vice President, Portfolio Leadership PAREXEL Dr. Shweta Uppal Kunal Shah Head- Clinical, Medical, Regulatory, Senior Manager Clinical Operations, Quality and Pharmacovigilance Eisai Novo Nordisk 14:50 Networking Break 15:20 Closing Remarks from Chairperson and End of Conference We Value Your Feedback Please visit the weblink below to complete your event feedback. At the end you will receive the password access to the speaker presentations (Slides will be available from 12 Dec onwards)